Skewed Fate and Hematopoiesis of CD34 HSPCs in Umbilical Cord Blood Amid the COVID-19 Pandemic
Overview
Authors
Affiliations
Umbilical cord blood (UCB) is an irreplaceable source for hematopoietic stem progenitor cells (HSPCs). However, the effects of SARS-CoV-2 infection and COVID-19 vaccination on UCB phenotype, specifically the HSPCs therein, are currently unknown. We thus evaluated any effects of SARS-CoV-2 infection and/or COVID-19 vaccination from the mother on the fate and functionalities of HSPCs in the UCB. The numbers and frequencies of HSPCs in the UCB decreased significantly in donors with previous SARS-CoV-2 infection and more so with COVID-19 vaccination via the induction of apoptosis, likely mediated by IFN-γ-dependent pathways. Two independent hematopoiesis assays, a colony forming unit assay and a mouse humanization assay, revealed skewed hematopoiesis of HSPCs obtained from donors delivered from mothers with SARS-CoV-2 infection history. These results indicate that SARS-CoV-2 infection and COVID-19 vaccination impair the functionalities and survivability of HSPCs in the UCB, which would make unprecedented concerns on the future of HSPC-based therapies.
Gambari R, Gamberini M, Cosenza L, Zuccato C, Finotti A J Clin Med. 2025; 14(1.
PMID: 39797371 PMC: 11722022. DOI: 10.3390/jcm14010289.
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4.
Spinello I, Saulle E, Quaranta M, Pelosi E, Castelli G, Cerio A Viruses. 2024; 16(1).
PMID: 38257782 PMC: 10818282. DOI: 10.3390/v16010082.
Enhanced fetal hematopoiesis in response to symptomatic SARS-CoV-2 infection during pregnancy.
Alkobtawi M, Ngo Q, Chapuis N, Fontaine R, El Khoury M, Tihy M Commun Med (Lond). 2023; 3(1):177.
PMID: 38082066 PMC: 10713620. DOI: 10.1038/s43856-023-00406-6.